
U.S. cardiovascular company IPOs 2006-2021
illustrated is the total number of initial public offerings (IPOs) for R&D stage therapeutic companies active in cardiovascular diseases and disorders in the U.S. from 2006 to 2021. As of third quarter 2021, three cardiovascular companies went public.